Mr. Chen Jieping, General Manager of EVT Medical, briefly reviewed the company's development history and R&D capabilities, and focused on the introduction of the Magsoo™ Ureteral Stent System. He stated that EVT Medical will continue to cooperate closely with clinical experts to jointly promote the continuous development and technological innovation in the field of endoluminal treatment of ureteral stricture.

Subsequently, the simulated practical operation and on-site communication provided the participating experts with an intuitive and in-depth platform to understand and experience this product.